ALT 0 3 0 3 B-clinical_variable
and 4 7 4 7 O
AST 8 11 8 11 B-clinical_variable
≤ 12 13 12 13 O
2.5 14 17 14 17 B-upper_bound
X 18 19 18 19 I-upper_bound
upper 20 25 20 25 I-upper_bound
limit 26 31 26 31 I-upper_bound
of 32 34 32 34 I-upper_bound
normal 35 41 35 41 I-upper_bound
( 42 43 42 43 I-upper_bound
ULN 43 46 43 46 I-upper_bound
) 46 47 46 47 I-upper_bound

Absolute 0 8 48 56 B-clinical_variable
lymphocyte 9 19 57 67 I-clinical_variable
count 20 25 68 73 I-clinical_variable
≥ 26 27 74 75 O
400 28 31 76 79 B-lower_bound
/ 31 32 79 80 I-lower_bound
μL 32 34 80 82 I-lower_bound

Absolute 0 8 83 91 B-clinical_variable
neutrophil 9 19 92 102 I-clinical_variable
count 20 25 103 108 I-clinical_variable
( 26 27 109 110 I-clinical_variable
ANC 27 30 110 113 I-clinical_variable
) 30 31 113 114 I-clinical_variable
≥ 32 33 115 116 O
1000 34 38 117 121 B-lower_bound
/ 38 39 121 122 I-lower_bound
μ 39 40 122 123 I-lower_bound

Accessible 0 10 124 134 O
tumors 11 17 135 141 B-cancer
for 18 21 142 145 O
sequential 22 32 146 156 O
biopsies 33 41 157 165 B-treatment
Terminology 42 53 166 177 O
Criteria 54 62 178 186 O
for 63 66 187 190 O
Adverse 67 74 191 198 O
Events 75 81 199 205 O
Version 82 89 206 213 O
4.0 90 93 214 217 O
( 94 95 218 219 O
CTCAE 95 100 219 224 O
v4.03 101 106 225 230 O
) 106 107 230 231 O
to 108 110 232 234 O
grade 111 116 235 240 O
1 117 118 241 242 O
or 119 121 243 245 O
better 122 128 246 252 O

Active 0 6 253 259 B-chronic_disease
hepatitis 7 16 260 269 I-chronic_disease
, 16 17 269 270 O
known 18 23 271 276 O
HIV 24 27 277 280 B-chronic_disease
, 27 28 280 281 O
or 29 31 282 284 O
other 32 37 285 290 O
condition 38 47 291 300 O
that 48 52 301 305 O
requires 53 61 306 314 O
immunosuppressive 62 79 315 332 B-treatment
therapy 80 87 333 340 I-treatment
, 87 88 340 341 O
including 89 98 342 351 O
current 99 106 352 359 O
use 107 110 360 363 O
of 111 113 364 366 O
high 114 118 367 371 O
dose 119 123 372 376 O
systemic 124 132 377 385 O
corticosteroids 133 148 386 401 B-treatment

Active 0 6 402 408 B-chronic_disease
uncontrolled 7 19 409 421 I-chronic_disease
serious 20 27 422 429 I-chronic_disease
infection 28 37 430 439 I-chronic_disease

Acute 0 5 440 445 B-chronic_disease
or 6 8 446 448 I-chronic_disease
chronic 9 16 449 456 I-chronic_disease
skin 17 21 457 461 I-chronic_disease
disorders 22 31 462 471 I-chronic_disease
that 32 36 472 476 O
would 37 42 477 482 O
interfere 43 52 483 492 O
with 53 57 493 497 O
subcutaneous 58 70 498 510 B-treatment
injection 71 80 511 520 I-treatment
of 81 83 521 523 I-treatment
the 84 87 524 527 I-treatment
vaccine 88 95 528 535 I-treatment
or 96 98 536 538 O
subsequent 99 109 539 549 O
assessment 110 120 550 560 O
of 121 123 561 563 O
potential 124 133 564 573 O
skin 134 138 574 578 O
reactions 139 148 579 588 O

Allergies 0 9 589 598 O
to 10 12 599 601 O
any 13 16 602 605 O
vaccine 17 24 606 613 B-allergy_name
, 24 25 613 614 O
that 26 30 615 619 O
after 31 36 620 625 O
discussion 37 47 626 636 O
with 48 52 637 641 O
Immunovaccine 53 66 642 655 O

Autoimmune 0 10 656 666 B-chronic_disease
disease 11 18 667 674 I-chronic_disease
, 18 19 674 675 O
such 20 24 676 680 O
as 25 27 681 683 O
systemic 28 36 684 692 B-chronic_disease
lupus 37 42 693 698 I-chronic_disease
erythematosis 43 56 699 712 I-chronic_disease
or 57 59 713 715 O
rheumatoid 60 70 716 726 B-chronic_disease
arthritis 71 80 727 736 I-chronic_disease
, 80 81 736 737 O
that 82 86 738 742 O
is 87 89 743 745 O
active 90 96 746 752 O
and 97 100 753 756 O
requires 101 109 757 765 O
current 110 117 766 773 O
immunosuppressive 118 135 774 791 B-treatment
therapy 136 143 792 799 I-treatment

Chemotherapy 0 12 800 812 B-treatment
within 13 19 813 819 O
3 20 21 820 821 B-upper_bound
weeks 22 27 822 827 I-upper_bound
prior 28 33 828 833 I-upper_bound
to 34 36 834 836 O
the 37 40 837 840 O
first 41 46 841 846 O
dose 47 51 847 851 O
of 52 54 852 854 O
trial 55 60 855 860 B-treatment
treatment 61 70 861 870 I-treatment

Distant 0 7 871 878 B-cancer
metastasis 8 18 879 889 I-cancer

Eastern 0 7 890 897 B-clinical_variable
Cooperative 8 19 898 909 I-clinical_variable
Oncology 20 28 910 918 I-clinical_variable
Group 29 34 919 924 I-clinical_variable
performance 35 46 925 936 I-clinical_variable
status 47 53 937 943 I-clinical_variable
( 54 55 944 945 I-clinical_variable
ECOG 55 59 945 949 I-clinical_variable
PS 60 62 950 952 I-clinical_variable
) 62 63 952 953 I-clinical_variable
≤ 64 65 954 955 O
2 66 67 956 957 B-upper_bound
( 68 69 958 959 O
Appendix 69 77 959 967 O
A 78 79 968 969 O
) 79 80 969 970 O

Inaccessible 0 12 971 983 O
tumor 13 18 984 989 B-chronic_disease
or 19 21 990 992 O
lack 22 26 993 997 O
of 27 29 998 1000 O
consent 30 37 1001 1008 O
for 38 41 1009 1012 O
sequential 42 52 1013 1023 B-treatment
biopsies 53 61 1024 1032 I-treatment

Men 0 3 1033 1036 B-gender
who 4 7 1037 1040 O
could 8 13 1041 1046 O
potentially 14 25 1047 1058 O
father 26 32 1059 1065 O
a 33 34 1066 1067 O
child 35 40 1068 1073 O
must 41 45 1074 1078 O
also 46 50 1079 1083 O
use 51 54 1084 1087 O
birth 55 60 1088 1093 O
control 61 68 1094 1101 O

Other 0 5 1102 1107 O
cancer 6 12 1108 1114 B-cancer
in 13 15 1115 1117 O
the 16 19 1118 1121 O
past 20 24 1122 1126 B-upper_bound
5 25 26 1127 1128 I-upper_bound
years 27 32 1129 1134 I-upper_bound

Platelet 0 8 1135 1143 B-clinical_variable
count 9 14 1144 1149 I-clinical_variable
≥ 15 16 1150 1151 O
100,000 17 24 1152 1159 B-lower_bound
/ 24 25 1159 1160 I-lower_bound
μL 25 27 1160 1162 I-lower_bound

Radiotherapy 0 12 1163 1175 B-treatment
for 13 16 1176 1179 O
primary 17 24 1180 1187 O
HPVOC 25 30 1188 1193 B-cancer
within 31 37 1194 1200 O
8 38 39 1201 1202 B-upper_bound
weeks 40 45 1203 1208 I-upper_bound

Relapsed 0 8 1209 1217 O
or 9 11 1218 1220 O
progressive 12 23 1221 1232 B-chronic_disease
disease 24 31 1233 1240 I-chronic_disease
at 32 34 1241 1243 O
the 35 38 1244 1247 O
primary 39 46 1248 1255 O
site 47 51 1256 1260 O
and/or 52 58 1261 1267 O
regional 59 67 1268 1276 O
lymph 68 73 1277 1282 O
nodes 74 79 1283 1288 O
after 80 85 1289 1294 O
initial 86 93 1295 1302 B-treatment
treatment 94 103 1303 1312 I-treatment
( 104 105 1313 1314 O
e.g. 105 109 1314 1318 O
Surgery 110 117 1319 1326 B-treatment
, 117 118 1326 1327 O
radiotherapy 119 131 1328 1340 B-treatment
or 132 134 1341 1343 O
chemoradiotherapy 135 152 1344 1361 B-treatment
) 152 153 1361 1362 O
with 154 158 1363 1367 O
no 159 161 1368 1370 O
potentially 162 173 1371 1382 O
curative 174 182 1383 1391 O
option 183 189 1392 1398 O
( 190 191 1399 1400 O
i.e. 191 195 1400 1404 O
surgery 196 203 1405 1412 B-treatment
or 204 206 1413 1415 O
radiation 207 216 1416 1425 B-treatment
) 216 217 1425 1426 O

Relapsed 0 8 1427 1435 O
or 9 11 1436 1438 O
progressive 12 23 1439 1450 O
disease 24 31 1451 1458 O
at 32 34 1459 1461 O
the 35 38 1462 1465 O
primary 39 46 1466 1473 O
site 47 51 1474 1478 O
and/or 52 58 1479 1485 O
regional 59 67 1486 1494 O
lymph 68 73 1495 1500 O
nodes 74 79 1501 1506 O
after 80 85 1507 1512 O
initial 86 93 1513 1520 O
treatment 94 103 1521 1530 O
( 104 105 1531 1532 O
e.g. 105 109 1532 1536 O
systemic 110 118 1537 1545 B-treatment
chemotherapy 119 131 1546 1558 I-treatment
) 131 132 1558 1559 O
with 133 137 1560 1564 O
no 138 140 1565 1567 O
potentially 141 152 1568 1579 O
curative 153 161 1580 1588 O
option 162 168 1589 1595 O
( 169 170 1596 1597 O
i.e. 170 174 1597 1601 O
surgery 175 182 1602 1609 B-treatment
or 183 185 1610 1612 O
chemoradiotherapy 186 203 1613 1630 B-treatment
) 203 204 1630 1631 O

Serum 0 5 1632 1637 B-clinical_variable
creatinine 6 16 1638 1648 I-clinical_variable
≤ 17 18 1649 1650 O
1.5 19 22 1651 1654 B-upper_bound
X 23 24 1655 1656 I-upper_bound
ULN 25 28 1657 1660 I-upper_bound

Uncontrolled 0 12 1661 1673 O
central 13 20 1674 1681 B-cancer
nervous 21 28 1682 1689 I-cancer
system 29 35 1690 1696 I-cancer
( 36 37 1697 1698 I-cancer
CNS 37 40 1698 1701 I-cancer
) 40 41 1701 1702 I-cancer
metastases 42 52 1703 1713 I-cancer
( 53 54 1714 1715 O
i.e. 54 58 1715 1719 O
known 59 64 1720 1725 O
CNS 65 68 1726 1729 B-cancer
lesions 69 76 1730 1737 I-cancer
that 77 81 1738 1742 O
are 82 85 1743 1746 O
radiographically 86 102 1747 1763 O
unstable 103 111 1764 1772 O
, 111 112 1772 1773 O
symptomatic 113 124 1774 1785 O
and/or 125 131 1786 1792 O
requiring 132 141 1793 1802 O
escalating 142 152 1803 1813 O
doses 153 158 1814 1819 O
of 159 161 1820 1822 O
corticosteroids 162 177 1823 1838 B-treatment
) 177 178 1838 1839 O

Women 0 5 1840 1845 B-gender
of 6 8 1846 1848 O
child 9 14 1849 1854 O
- 14 15 1854 1855 O
bearing 15 22 1855 1862 O
potential 23 32 1863 1872 O
( 33 34 1873 1874 O
WOCBP 34 39 1874 1879 O
) 39 40 1879 1880 O
must 41 45 1881 1885 O
be 46 48 1886 1888 O
willing 49 56 1889 1896 B-contraception_consent
to 57 59 1897 1899 I-contraception_consent
use 60 63 1900 1903 I-contraception_consent
acceptable 64 74 1904 1914 I-contraception_consent
means 75 80 1915 1920 I-contraception_consent
of 81 83 1921 1923 I-contraception_consent
birth 84 89 1924 1929 I-contraception_consent
control 90 97 1930 1937 I-contraception_consent

alopecia 0 8 1938 1946 B-chronic_disease

based 0 5 1947 1952 O
on 6 8 1953 1955 O
expression 9 19 1956 1966 O
of 20 22 1967 1969 O
HPV 23 26 1970 1973 B-cancer
type16 27 33 1974 1980 I-cancer
in 34 36 1981 1983 O
immunohistochemistry 37 57 1984 2004 B-treatment
and/or 58 64 2005 2011 O
HPV 65 68 2012 2015 B-chronic_disease
16 69 71 2016 2018 I-chronic_disease
DNA 72 75 2019 2022 O
analysis 76 84 2023 2031 O
by 85 87 2032 2034 O
ISH 88 91 2035 2038 O
of 92 94 2039 2041 O
tumor 95 100 2042 2047 B-cancer
tissue 101 107 2048 2054 I-cancer
from 108 112 2055 2059 O
the 113 116 2060 2063 O
primary 117 124 2064 2071 O
or 125 127 2072 2074 O
metastatic 128 138 2075 2085 B-cancer
lesions 139 146 2086 2093 I-cancer

carcinoma 0 9 2094 2103 B-cancer
in 10 12 2104 2106 I-cancer
situ 13 17 2107 2111 I-cancer
of 18 20 2112 2114 O
the 21 24 2115 2118 O
cervix 25 31 2119 2125 O
or 32 34 2126 2128 O
bladder 35 42 2129 2136 O

cervical 0 8 2137 2145 B-cancer
cancer 9 15 2146 2152 I-cancer

dysphagia 0 9 2153 2162 B-chronic_disease

mucositis 0 9 2163 2172 B-chronic_disease

non 0 3 2173 2176 B-cancer
- 3 4 2176 2177 I-cancer
melanomatous 4 16 2177 2189 I-cancer
skin 17 21 2190 2194 I-cancer
cancer 22 28 2195 2201 I-cancer

radiotherapy 0 12 2202 2214 B-treatment
for 13 16 2215 2218 O
any 17 20 2219 2222 O
other 21 26 2223 2228 O
reason 27 33 2229 2235 O
within 34 40 2236 2242 O
3 41 42 2243 2244 B-upper_bound
weeks 43 48 2245 2250 I-upper_bound
prior 49 54 2251 2256 I-upper_bound
to 55 57 2257 2259 O
the 58 61 2260 2263 O
first 62 67 2264 2269 O
dose 68 72 2270 2274 O
of 73 75 2275 2277 O
trial 76 81 2278 2283 B-treatment
treatment 82 91 2284 2293 I-treatment

